Passive Biotech

iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

$19.32

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Genomics Immunology and Healthcare ETF IDNA
Fund Size
$158 Million
Dividend
1.2%
Fees
0.47%
Total Stock Market Index Fund VTI
Fund Size
$1.78 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.35 Trillion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$447 Billion
Dividend
3.0%
Fees
0.07%
View 1303 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $52 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.97 %
Beta Indicates the relationship between the price performance of a share and the market. 0.9852
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 74.14
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -23.69
Profitable Companies 44
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 65.67
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.73
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.1
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -8.58
Enterprise Value to Revenue Enterprise value divided by revenue 476.97
Total Debt to Enterprise Value Total debt divided by enterprise value 0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.3221
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -11369.62%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -6.72%
Return on Assets Indicates a company's profitability in relation to its total assets. -11.36%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -12.21%

Industries

Healthcare 79.6%
Other 5.6%
N/A 14.8%

Market cap

Micro Cap 2%
Small Cap 24%
Mid Cap 17%
Large Cap 43%
Mega Cap 14%

54 Investments

P/E-Ratio
Total Investment
Weight
BlackRock Funds III logo

BlackRock Funds III

P/E-Ratio
n/a
Total Investment
$17.5 Million
Weight
14.2%
Sanofi SA logo

SNY - Health Technology

Sanofi SA

P/E-Ratio
18.2
Total Investment
$6.02 Million
Weight
4.9%
BeiGene Ltd logo

BGNE - Manufacturing

BeiGene Ltd

P/E-Ratio
-72.1
Total Investment
$5.88 Million
Weight
4.8%
Roche Holding AG logo

RHHVF - Health Technology

Roche Holding AG

P/E-Ratio
24.8
Total Investment
$5.79 Million
Weight
4.7%
AstraZeneca PLC logo

AZN - Health Technology

AstraZeneca PLC

P/E-Ratio
27.2
Total Investment
$5.58 Million
Weight
4.5%
GSK PLC logo

GSK - Manufacturing

GSK PLC

P/E-Ratio
17.9
Total Investment
$5.49 Million
Weight
4.5%
BioNTech SE logo

BNTX - Manufacturing

BioNTech SE

P/E-Ratio
-30.0
Total Investment
$5.48 Million
Weight
4.5%
Twist Bioscience Corp logo

TWST - Professional, Scientific, and Technical Services

Twist Bioscience Corp

P/E-Ratio
-9.6
Total Investment
$5.28 Million
Weight
4.3%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
537.0
Total Investment
$5.27 Million
Weight
4.3%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
11.0
Total Investment
$5.17 Million
Weight
4.2%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
19.7
Total Investment
$4.99 Million
Weight
4.1%
Takeda Pharmaceutical Co Ltd logo

TAK - Manufacturing

Takeda Pharmaceutical Co Ltd

P/E-Ratio
32.3
Total Investment
$4.96 Million
Weight
4.0%
Genmab A/S logo

GMAB - Professional, Scientific, and Technical Services

Genmab A/S

P/E-Ratio
10.8
Total Investment
$4.83 Million
Weight
3.9%
Revolution Medicines Inc logo

RVMD - Manufacturing

Revolution Medicines Inc

P/E-Ratio
-11.7
Total Investment
$4.82 Million
Weight
3.9%
Moderna Inc logo

MRNA - Manufacturing

Moderna Inc

P/E-Ratio
-2.8
Total Investment
$4.78 Million
Weight
3.9%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
12.5
Total Investment
$4.67 Million
Weight
3.8%
SpringWorks Therapeutics Inc logo

SWTX - Manufacturing

SpringWorks Therapeutics Inc

P/E-Ratio
-13.3
Total Investment
$4.42 Million
Weight
3.6%
Arcellx Inc logo

ACLX

Arcellx Inc

P/E-Ratio
-77.7
Total Investment
$4.35 Million
Weight
3.5%
Janux Therapeutics Inc logo

JANX - Professional, Scientific, and Technical Services

Janux Therapeutics Inc

P/E-Ratio
-21.1
Total Investment
$3.61 Million
Weight
2.9%
Geron Corp logo

GERN - Manufacturing

Geron Corp

P/E-Ratio
-4.4
Total Investment
$2.9 Million
Weight
2.4%
BioCryst Pharmaceuticals Inc logo

BCRX - Manufacturing

BioCryst Pharmaceuticals Inc

P/E-Ratio
-38.9
Total Investment
$2.68 Million
Weight
2.2%
Iovance Biotherapeutics Inc logo

IOVA - Manufacturing

Iovance Biotherapeutics Inc

P/E-Ratio
-1.4
Total Investment
$2.59 Million
Weight
2.1%
Novavax Inc logo

NVAX - Manufacturing

Novavax Inc

P/E-Ratio
-5.1
Total Investment
$2.38 Million
Weight
1.9%
Xencor Inc logo

XNCR - Manufacturing

Xencor Inc

P/E-Ratio
-2.6
Total Investment
$2.16 Million
Weight
1.8%
Vir Biotechnology Inc logo

VIR - Professional, Scientific, and Technical Services

Vir Biotechnology Inc

P/E-Ratio
-2.2
Total Investment
$1.63 Million
Weight
1.3%